Generation Bio (GBIO) Competitors $0.78 -0.03 (-4.04%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$0.82 +0.04 (+5.51%) As of 01/31/2025 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends GBIO vs. HRTX, AMLX, NGNE, ATAI, DMAC, URGN, ELDN, LFCR, FHTX, and BNTCShould you be buying Generation Bio stock or one of its competitors? The main competitors of Generation Bio include Heron Therapeutics (HRTX), Amylyx Pharmaceuticals (AMLX), Neurogene (NGNE), Atai Life Sciences (ATAI), DiaMedica Therapeutics (DMAC), UroGen Pharma (URGN), Eledon Pharmaceuticals (ELDN), Lifecore Biomedical (LFCR), Foghorn Therapeutics (FHTX), and Benitec Biopharma (BNTC). These companies are all part of the "pharmaceutical products" industry. Generation Bio vs. Heron Therapeutics Amylyx Pharmaceuticals Neurogene Atai Life Sciences DiaMedica Therapeutics UroGen Pharma Eledon Pharmaceuticals Lifecore Biomedical Foghorn Therapeutics Benitec Biopharma Heron Therapeutics (NASDAQ:HRTX) and Generation Bio (NASDAQ:GBIO) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, community ranking, earnings, risk, institutional ownership, profitability and dividends. Does the media prefer HRTX or GBIO? In the previous week, Heron Therapeutics had 2 more articles in the media than Generation Bio. MarketBeat recorded 4 mentions for Heron Therapeutics and 2 mentions for Generation Bio. Heron Therapeutics' average media sentiment score of 0.70 beat Generation Bio's score of 0.43 indicating that Heron Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Heron Therapeutics Positive Generation Bio Neutral Do analysts rate HRTX or GBIO? Heron Therapeutics presently has a consensus price target of $5.67, indicating a potential upside of 233.33%. Generation Bio has a consensus price target of $6.50, indicating a potential upside of 733.33%. Given Generation Bio's higher probable upside, analysts plainly believe Generation Bio is more favorable than Heron Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Heron Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Generation Bio 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders believe in HRTX or GBIO? 80.0% of Heron Therapeutics shares are owned by institutional investors. Comparatively, 95.2% of Generation Bio shares are owned by institutional investors. 5.8% of Heron Therapeutics shares are owned by company insiders. Comparatively, 21.1% of Generation Bio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community believe in HRTX or GBIO? Heron Therapeutics received 622 more outperform votes than Generation Bio when rated by MarketBeat users. However, 70.49% of users gave Generation Bio an outperform vote while only 68.84% of users gave Heron Therapeutics an outperform vote. CompanyUnderperformOutperformHeron TherapeuticsOutperform Votes66568.84% Underperform Votes30131.16% Generation BioOutperform Votes4370.49% Underperform Votes1829.51% Which has preferable valuation and earnings, HRTX or GBIO? Heron Therapeutics has higher revenue and earnings than Generation Bio. Heron Therapeutics is trading at a lower price-to-earnings ratio than Generation Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeron Therapeutics$127.04M2.04-$110.56M-$0.18-9.44Generation Bio$5.90M8.83-$126.61M-$2.19-0.36 Which has more risk and volatility, HRTX or GBIO? Heron Therapeutics has a beta of 1.6, indicating that its stock price is 60% more volatile than the S&P 500. Comparatively, Generation Bio has a beta of 2.72, indicating that its stock price is 172% more volatile than the S&P 500. Is HRTX or GBIO more profitable? Heron Therapeutics has a net margin of -20.31% compared to Generation Bio's net margin of -782.86%. Heron Therapeutics' return on equity of 0.00% beat Generation Bio's return on equity.Company Net Margins Return on Equity Return on Assets Heron Therapeutics-20.31% N/A -12.72% Generation Bio -782.86%-104.85%-49.54% SummaryHeron Therapeutics beats Generation Bio on 10 of the 17 factors compared between the two stocks. Get Generation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GBIO vs. The Competition Export to ExcelMetricGeneration BioPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$57.42M$6.86B$5.58B$9.11BDividend YieldN/A2.90%5.32%3.99%P/E Ratio-0.369.6789.2618.26Price / Sales8.83301.931,254.4080.65Price / CashN/A73.5045.9637.70Price / Book0.255.275.124.70Net Income-$126.61M$136.98M$111.40M$224.47M7 Day Performance-16.80%-0.73%2.33%-0.20%1 Month Performance-26.42%0.16%3.20%0.57%1 Year Performance-59.79%7.59%24.64%20.29% Generation Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GBIOGeneration Bio3.6695 of 5 stars$0.78-4.0%$6.50+733.3%-58.5%$57.42M$5.90M-0.36150Short Interest ↑HRTXHeron Therapeutics3.7609 of 5 stars$1.63+3.8%$5.67+247.6%-29.5%$247.92M$127.04M-9.06300Analyst DowngradeNews CoverageAMLXAmylyx Pharmaceuticals3.0869 of 5 stars$3.60+2.9%$7.33+103.7%-77.2%$246.78M$380.79M-0.94200Short Interest ↑Analyst RevisionNews CoverageNGNENeurogene3.2289 of 5 stars$16.60-5.8%$60.83+266.5%-47.4%$246.51MN/A0.0090News CoverageATAIAtai Life Sciences2.4497 of 5 stars$1.46+5.0%$9.00+516.4%-12.9%$244.99M$310,000.00-1.8080Analyst ForecastNews CoverageDMACDiaMedica Therapeutics1.5277 of 5 stars$5.71+0.7%$7.00+22.6%+104.3%$244.16MN/A-10.2020Short Interest ↑News CoverageHigh Trading VolumeURGNUroGen Pharma4.0619 of 5 stars$10.27-2.4%$43.70+325.5%-29.9%$240.87M$89.36M-3.26200ELDNEledon Pharmaceuticals3.0962 of 5 stars$4.02-0.2%$16.00+298.0%+153.9%$240.16MN/A-2.0010Analyst ForecastShort Interest ↓LFCRLifecore Biomedical2.7106 of 5 stars$6.48+0.6%$8.00+23.5%-9.0%$239.95M$128.26M-11.57690FHTXFoghorn Therapeutics2.5675 of 5 stars$4.31+2.6%$13.80+220.2%+31.8%$239.59M$34.15M-2.24120Analyst UpgradeShort Interest ↓Analyst RevisionNews CoverageBNTCBenitec Biopharma2.641 of 5 stars$10.30-6.9%$24.43+137.2%+308.9%$239.17M$80,000.000.0020News Coverage Related Companies and Tools Related Companies HRTX Alternatives AMLX Alternatives NGNE Alternatives ATAI Alternatives DMAC Alternatives URGN Alternatives ELDN Alternatives LFCR Alternatives FHTX Alternatives BNTC Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GBIO) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredElon’s ultimate power move?THE ELON SHOCK All of Elon Musk’s strange behavior may soon make sense… and impact the markets in a way no ...Altimetry | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump loves DeepSeekPresident Trump could be ecstatic. And it's all thanks to DeepSeek. The secretive Chinese startup just r...Weiss Ratings | SponsoredNew catalyst on Wall Street’s radar for this week (NOT Trump)Wall Street is already looking past Trump… To a new catalyst on the near horizon that could be even bigger ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Generation Bio Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Generation Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GBIO Stock Alerts